Gene · 7150
Papers4,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Oncoproteins E6 and E7 upregulate topoisomerase I to activate the cGAS-PD-L1 pathway in cervical cancer development. | Front Pharmacol | 2024 | 39156107 | PubTator, text mining | PubMed |
| FPWT: Filter pruning via wavelet transform for CNNs. | Neural Netw | 2024 | 39098265 | PubTator, text mining | PubMed |
| Annual report text's positive tone and corporate green innovation: Evidence from China. | PLoS One | 2024 | 39074115 | PubTator, text mining | PubMed |
| TDP1 phosphorylation by CDK1 in mitosis promotes MUS81-dependent repair of trapped Top1-DNA covalent complexes. | EMBO J | 2024 | 39014228 | PubTator, text mining | PubMed |
| Downstream-of-gene (DoG) transcripts contribute to an imbalance in the cancer cell transcriptome. | Sci Adv | 2024 | 38959318 | PubTator, text mining | PubMed |
| Enhancing deep neural network training efficiency and performance through linear prediction. | Sci Rep | 2024 | 38956088 | PubTator, text mining | PubMed |
| Harmine inhibits pulmonary fibrosis through regulating DNA damage repair-related genes and activation of TP53-Gadd45α pathway. | Int Immunopharmacol | 2024 | 38924867 | PubTator, text mining | PubMed |
| PredGCN: a Pruning-enabled Gene-Cell Net for automatic cell annotation of single cell transcriptome data. | Bioinformatics | 2024 | 38924517 | PubTator, text mining | PubMed |
| Variable Temporal Length Training for Action Recognition CNNs. | Sensors (Basel) | 2024 | 38894195 | PubTator, text mining | PubMed |
| The Discovery of Selective Protein Arginine Methyltransferase 5 Inhibitors in the Management of β-Thalassemia through Computational Methods. | Molecules | 2024 | 38893537 | PubTator, text mining | PubMed |
| In vitro evolution and whole genome analysis to study chemotherapy drug resistance in haploid human cells. | Sci Rep | 2024 | 38886371 | PubTator, text mining | PubMed |
Mechanism of Preventing Recurrence of Stage II-III Colorectal Cancer Metastasis with Immuno-inflammatory and Hypoxic Microenvironment by a Four Ingredients Chinese Herbal Formula: A Bioinformatics and Network Pharmacology Analysis. | Curr Pharm Des | 2024 | 38867534 | PubTator, text mining | PubMed |
| RA-Net: reverse attention for generalizing residual learning. | Sci Rep | 2024 | 38834620 | PubTator, text mining | PubMed |
| Natural Immunomodulatory Agents as a Complementary Therapy for Poxviruses. | Adv Exp Med Biol | 2024 | 38801589 | PubTator, text mining | PubMed |
| Synergistic Nanomedicine Delivering Topoisomerase I Toxin (SN-38) and Inhibitors of Polynucleotide Kinase 3'-Phosphatase (PNKP) for Enhanced Treatment of Colorectal Cancer. | Mol Pharm | 2024 | 38785196 | PubTator, text mining | PubMed |
| Experimental and computational study on anti-gastric cancer activity and mechanism of evodiamine derivatives. | Front Pharmacol | 2024 | 38783957 | PubTator, text mining | PubMed |
| Nuclear-penetrating scleroderma autoantibody inhibits topoisomerase 1 cleavage complex formation. | Biochem Biophys Res Commun | 2024 | 38759301 | PubTator, text mining | PubMed |
| Phytoconstituents of Artemisia Annua as potential inhibitors of SARS CoV2 main protease: an in silico study. | BMC Infect Dis | 2024 | 38750422 | PubTator, text mining | PubMed |
| On the utility of ultrafast MS1-only proteomics in drug target discovery studies based on thermal proteome profiling method. | Anal Bioanal Chem | 2024 | 38744720 | PubTator, text mining | PubMed |
| Two-Phase Electrosynthesis of Dihydroxycoumestans: Discovery of a New Scaffold for Topoisomerase I Poison. | Chemistry | 2024 | 38736421 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7150/papers?page=16